Neose Technologies, Inc. (NTEC) Announces Sale of Assets to Novo Nordisk and BioGeneriX AG for $43 Million
Neose Technologies, Inc. (Nasdaq GM: NTEC), a clinical-stage biopharmaceutical company focused on the development of next-generation therapeutic proteins that are…